MKKS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.829600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.427410E-01
Normal-vs-Stage2
7.579200E-01
Normal-vs-Stage3
1.703830E-01
Normal-vs-Stage4
3.766600E-01
Stage1-vs-Stage2
5.059700E-03
Stage1-vs-Stage3
5.403200E-03
Stage1-vs-Stage4
1.518260E-02
Stage2-vs-Stage3
1.583180E-01
Stage2-vs-Stage4
4.756200E-01
Stage3-vs-Stage4
4.539800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.571600E-01
Normal-vs-AfricanAmerican
7.807800E-01
Normal-vs-Asian
2.710600E-01
Caucasian-vs-AfricanAmerican
7.903400E-01
Caucasian-vs-Asian
1.123640E-01
AfricanAmerican-vs-Asian
8.160500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.245800E-01
Normal-vs-Female
8.056800E-01
Male-vs-Female
2.446800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.528000E-01
Normal-vs-Age(41-60Yrs)
8.022800E-01
Normal-vs-Age(61-80Yrs)
8.529200E-01
Normal-vs-Age(81-100Yrs)
9.501800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.558000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.958800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.887800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.162240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.098600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.209000E-01
Normal-vs-Daily Drinker
8.088800E-01
Normal-vs-Weekly Drinker
7.604600E-01
Normal-vs-Occasional Drinker
7.855000E-01
Normal-vs-Social Drinker
7.642600E-01
Non Drinker-vs-Daily Drinker
9.736800E-01
Non Drinker-vs-Weekly Drinker
9.077800E-01
Non Drinker-vs-Occasional Drinker
2.022800E-01
Non Drinker-vs-Social Drinker
2.721800E-01
Daily Drinker-vs-Weekly Drinker
9.055000E-01
Daily Drinker-vs-Occasional Drinker
3.440800E-01
Daily Drinker-vs-Social Drinker
3.286400E-01
Weekly Drinker-vs-Occasional Drinker
3.311800E-01
Weekly Drinker-vs-Social Drinker
3.325800E-01
Occasional Drinker-vs-Social Drinker
8.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.196400E-01
Normal-vs-Grade 2
9.189600E-01
Normal-vs-Grade 3
9.339800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.200400E-02
Grade 1-vs-Grade 3
2.060400E-02
Grade 1-vs-Grade 4
6.196400E-01
Grade 2-vs-Grade 3
7.830400E-01
Grade 2-vs-Grade 4
9.189600E-01
Grade 3-vs-Grade 4
9.339800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.676800E-01
Normal-vs-NonDiabetic
8.853400E-01
Diabetic-vs-NonDiabetic
3.347900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.274400E-01
Normal-vs-NoPancreatitis
9.724600E-01
Pancreatitis-vs-NoPancreatitis
1.428000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.184200E-01
Normal-vs-N1
8.238000E-01
N0-vs-N1
1.616980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.492400E-01
Normal-vs-TP53-NonMutant
7.296000E-01
TP53-Mutant-vs-TP53-NonMutant
2.874400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
